MDAI 1.21 Spectral AI, Inc.

Stock List / Spectral AI, Inc.

Range:	0.824-3.721	Vol Avg:	191698	Last Div:	0	Changes:	-0.03
Beta:	0.56	Cap:	0.02B	Currency:	USD	Exchange:	NASDAQ
Sector:	Healthcare			IPO:	Tue Apr 06 2021	Empoloyees:	78
CUSIP:	84757T105	CIK:	0001833498	ISIN:	US84757T1051	Country:	US
CEO:	Mr. Wensheng Fan			Website:	https://www.spectral-ai.com

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Stock Details

Positive 0.24

Spectral AI founder returns as board chairman

Spectral AI Inc (NASDAQ:MDAI) announced that its founder Dr J Michael DiMaio has been appo...

proactiveinvestors.com·Tue Oct 15 2024

Positive 0.52

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” ...

globenewswire.com·Mon Oct 14 2024

Positive 0.30

Spectral AI completes proof-of-concept for wound measurement technology

Spectral AI Inc (NASDAQ:MDAI) announced the completion of a proof-of-concept module of its...

proactiveinvestors.com·Thu Oct 03 2024

Positive 0.35

Spectral AI Completes Proof of Concept for Wound Measurement Technology

Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient...

globenewswire.com·Thu Oct 03 2024

Neutral -0.10

Spectral AI reaches key milestone in US burn study, expands clinical trial sites

Spectral AI Inc (NASDAQ:MDAI) announced a significant milestone in its U.S. Burn Pivotal S...

proactiveinvestors.com·Tue Sep 24 2024

Positive 0.28

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI”...

globenewswire.com·Tue Sep 24 2024

Positive 0.68

Spectral AI preparing to seek FDA approval of DeepView burn assessment device

Spectral AI Inc (NASDAQ:MDAI) has outlined its US regulatory strategy for its DeepView AI ...

proactiveinvestors.com·Tue Sep 17 2024

Positive 0.39

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI”...

globenewswire.com·Tue Sep 17 2024

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.